Henry Schein, Inc. (NASDAQ:HSIC) Holdings Lifted by River Global Investors LLP

River Global Investors LLP increased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 12.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 140,386 shares of the company’s stock after purchasing an additional 15,336 shares during the period. Henry Schein accounts for 2.2% of River Global Investors LLP’s holdings, making the stock its 7th biggest holding. River Global Investors LLP owned 0.11% of Henry Schein worth $10,237,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Empirical Finance LLC raised its holdings in shares of Henry Schein by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after acquiring an additional 160 shares in the last quarter. Cromwell Holdings LLC raised its holdings in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares in the last quarter. Covestor Ltd raised its holdings in shares of Henry Schein by 12.8% during the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after acquiring an additional 171 shares in the last quarter. Simplify Asset Management Inc. raised its holdings in shares of Henry Schein by 5.0% during the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after acquiring an additional 175 shares in the last quarter. Finally, Sequoia Financial Advisors LLC raised its holdings in shares of Henry Schein by 3.2% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock worth $364,000 after acquiring an additional 176 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Trading Down 2.1 %

Henry Schein stock traded down $1.43 during mid-day trading on Friday, hitting $68.00. The company’s stock had a trading volume of 871,840 shares, compared to its average volume of 1,518,488. The company has a 50 day moving average of $70.51 and a 200-day moving average of $69.73. The stock has a market cap of $8.48 billion, a PE ratio of 27.98, a P/E/G ratio of 2.00 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.42. Henry Schein, Inc. has a one year low of $62.12 and a one year high of $82.63.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the prior year, the company earned $1.32 EPS. The business’s revenue was up .4% compared to the same quarter last year. On average, research analysts anticipate that Henry Schein, Inc. will post 4.76 EPS for the current year.

Analyst Upgrades and Downgrades

HSIC has been the topic of several recent research reports. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. UBS Group cut their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Robert W. Baird cut their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Finally, Barrington Research reissued an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research report on Wednesday. One analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Henry Schein presently has an average rating of “Hold” and a consensus target price of $77.50.

Insider Transactions at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.